|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002645,
umls-concept:C0008976,
umls-concept:C0025872,
umls-concept:C0028978,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0055856,
umls-concept:C0079488,
umls-concept:C0080194,
umls-concept:C0205195,
umls-concept:C0231204
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1999-8-19
|
|
pubmed:abstractText |
The impact of metronidazole resistance on the efficacy of proton pump inhibitor based triple therapies remains unclear.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
883-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10383522-Adolescent,
pubmed-meshheading:10383522-Adult,
pubmed-meshheading:10383522-Aged,
pubmed-meshheading:10383522-Amoxicillin,
pubmed-meshheading:10383522-Anti-Bacterial Agents,
pubmed-meshheading:10383522-Anti-Ulcer Agents,
pubmed-meshheading:10383522-Clarithromycin,
pubmed-meshheading:10383522-Drug Administration Schedule,
pubmed-meshheading:10383522-Drug Resistance, Microbial,
pubmed-meshheading:10383522-Drug Therapy, Combination,
pubmed-meshheading:10383522-Female,
pubmed-meshheading:10383522-Helicobacter Infections,
pubmed-meshheading:10383522-Helicobacter pylori,
pubmed-meshheading:10383522-Humans,
pubmed-meshheading:10383522-Male,
pubmed-meshheading:10383522-Metronidazole,
pubmed-meshheading:10383522-Microbial Sensitivity Tests,
pubmed-meshheading:10383522-Middle Aged,
pubmed-meshheading:10383522-Omeprazole,
pubmed-meshheading:10383522-Penicillins,
pubmed-meshheading:10383522-Peptic Ulcer,
pubmed-meshheading:10383522-Proton Pumps,
pubmed-meshheading:10383522-Single-Blind Method
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
|
|
pubmed:affiliation |
Department of Internal Medicine, Red Cross Hospital, The Hague, The Netherlands. m.h.houben@wxs.nl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
